Keros Therapeutics
KROS
KROS
152 hedge funds and large institutions have $1.44B invested in Keros Therapeutics in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 40 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
3% more funds holding
Funds holding: 147 → 152 (+5)
0.03% more ownership
Funds ownership: 87.25% → 87.28% (+0.03%)
31% less capital invested
Capital invested by funds: $2.08B → $1.44B (-$640M)
Holders
152
Holding in Top 10
5
Calls
$1.75M
Puts
$86K
Top Buyers
| 1 | +$15.9M | |
| 2 | +$12.1M | |
| 3 | +$12M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$11.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.66M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$15.6M | |
| 3 | -$13.7M | |
| 4 |
CWM
CIBC World Markets
New York
|
-$13.2M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$11.5M |